🇺🇸 SKYRIZI in United States

29,125 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 29,125

Most-reported reactions

1. Psoriasis — 7,313 reports (25.11%)
2. Drug Ineffective — 3,227 reports (11.08%)
3. Pain — 2,847 reports (9.78%)
4. Fatigue — 2,747 reports (9.43%)
5. Arthralgia — 2,697 reports (9.26%)
6. Pruritus — 2,503 reports (8.59%)
7. Covid-19 — 2,210 reports (7.59%)
8. Surgery — 1,875 reports (6.44%)
9. Fall — 1,856 reports (6.37%)
10. Death — 1,850 reports (6.35%)

Source database →

Frequently asked questions

Is SKYRIZI approved in United States?

SKYRIZI does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for SKYRIZI in United States?

Chong Kun Dang Pharmaceutical is the originator. The local marketing authorisation holder may differ — check the official source linked above.